Form 4 for KALA KALA BIO, Inc.
Accepted 2023-06-23 00:00:00 ET · period of report 2023-06-22 · accession 0001415889-23-010285 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-23 | 2023-06-22 | KALA | Reumuth Mary | CFO | A - Grant | $0.00 | +36.1K | 62.8K | +136% | $0 |
| D | 2023-06-23 | 2023-06-22 | KALA | Reumuth Mary | CFO | A - Grant | $0.00 | +48.2K | 48.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-22 | A | A | 36,144 | $0.00 | 62,763 | D | — | — | (F1) Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with Issuer, the RSUs will vest as to 1/3 of the shares underlying the RSUs on June 22, 2024, as to 1/3 of the shares underlying the RSUs on June 22, 2025 and as to the final 1/3 of shares underlying the RSUs on June 22, 2026. (F2) Includes 60,556 unvested RSUs. |
| 2 | Derivative | Stock Option (right to buy) | 2023-06-22 | A | A | 48,192 | $0.00 | 48,192 | D | $14.56 · — to 2033-06-21 | 48,192 Common Stock | (F3) This option was granted on June 22, 2023 and vests over four years beginning on the vesting commencement date of June 22, 2023, with 25% of the shares underlying the option vesting on June 22, 2024, and an additional 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter. |